X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-08-12 | PBYI | Miller Michael Patrick | Dir | S - Sale | $3.49 | -23,358 | 47,000 | -33% | -$81,466 | ||||||
2024-07-17 | PBYI | Nougues Maximo F | CFO | S - Sale | $3.70 | -4,156 | 162,522 | -2% | -$15,382 | ||||||
2024-07-17 | PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | S - Sale | $3.70 | -2,598 | 118,388 | -2% | -$9,615 | ||||||
2024-07-17 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $3.70 | -3,637 | 133,227 | -3% | -$13,461 | ||||||
2024-07-17 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $3.70 | -21,920 | 7,063,515 | 0% | -$81,128 | ||||||
2024-07-02 | PBYI | Nougues Maximo F | CFO | S - Sale | $3.27 | -5,295 | 166,678 | -3% | -$17,307 | ||||||
2024-07-02 | PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | S - Sale | $3.27 | -6,051 | 120,986 | -5% | -$19,778 | ||||||
2024-07-02 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $3.27 | -4,349 | 136,864 | -3% | -$14,215 | ||||||
2024-07-02 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $3.27 | -18,885 | 7,085,435 | 0% | -$61,726 | ||||||
2024-06-13 | PBYI | Wilson Troy Edward | Dir | S - Sale | $3.33 | -27,000 | 900 | -97% | -$89,902 | ||||||
2024-06-13 | PBYI | Stuglik Brian M | Dir | S - Sale | $3.39 | -9,900 | 49,058 | -17% | -$33,528 | ||||||
2024-06-13 | PBYI | Senderowicz Adrian | Dir | S - Sale | $3.33 | -27,000 | 0 | -100% | -$89,818 | ||||||
2024-06-13 | PBYI | Moyes Jay M | Dir | S - Sale | $3.34 | -22,000 | 21,322 | -51% | -$73,467 | ||||||
2024-06-13 | PBYI | Dorval Allison | Dir | S - Sale | $3.37 | -11,000 | 33,000 | -25% | -$37,096 | ||||||
2023-12-04 | PBYI | Wong Alvin F | Chief Scientific Officer | S - Sale | $3.76 | -280 | 97,934 | 0% | -$1,053 | ||||||
2024-01-03 | PBYI | Wong Alvin F | Chief Scientific Officer | S - Sale | $4.49 | -7,733 | 98,214 | -7% | -$34,689 | ||||||
2024-01-03 | PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | S - Sale | $4.49 | -12,956 | 99,970 | -11% | -$58,119 | ||||||
2024-01-03 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $4.49 | -41,396 | 6,936,947 | -1% | -$185,698 | ||||||
2024-01-03 | PBYI | Nougues Maximo F | CFO | S - Sale | $4.49 | -15,682 | 128,666 | -11% | -$70,348 | ||||||
2024-01-03 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $4.49 | -8,358 | 103,319 | -7% | -$37,493 | ||||||
2023-11-07 | PBYI | Miller Michael Patrick | Dir | S - Sale | $2.83 | -25,000 | 43,358 | -37% | -$70,803 | ||||||
2023-07-03 | PBYI | Wong Alvin F | Chief Scientific Officer | S - Sale | $3.31 | -6,938 | 105,947 | -6% | -$22,973 | ||||||
2023-07-03 | PBYI | Nougues Maximo F | CFO | S - Sale | $3.31 | -14,680 | 144,348 | -9% | -$48,608 | ||||||
2023-07-03 | PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | S - Sale | $3.31 | -12,103 | 112,926 | -10% | -$40,075 | ||||||
2023-07-03 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $3.31 | -7,809 | 111,677 | -7% | -$25,857 | ||||||
2023-07-03 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $3.31 | -60,698 | 6,978,343 | -1% | -$200,983 | ||||||
2023-06-13 | PBYI | Wilson Troy Edward | Dir | S - Sale | $3.45 | -27,000 | 27,900 | -49% | -$93,269 | ||||||
2023-06-13 | PBYI | Moyes Jay M | Dir | S - Sale | $3.45 | -22,000 | 43,322 | -34% | -$75,970 | ||||||
2023-06-13 | PBYI | Stuglik Brian M | Dir | S - Sale | $3.46 | -9,900 | 58,958 | -14% | -$34,252 | ||||||
2023-06-13 | PBYI | Senderowicz Adrian | Dir | S - Sale | $3.45 | -27,000 | 27,000 | -50% | -$93,280 | ||||||
2023-06-13 | PBYI | Dorval Allison | Dir | S - Sale | $3.45 | -10,000 | 44,000 | -19% | -$34,500 | ||||||
2023-06-13 | PBYI | Miller Michael Patrick | Dir | S - Sale | $3.45 | -13,500 | 68,358 | -16% | -$46,630 | ||||||
2023-06-02 | PBYI | Wong Alvin F | Chief Scientific Officer | S - Sale | $3.45 | -269 | 112,885 | 0% | -$928 | ||||||
2023-01-03 | PBYI | Wong Alvin F | Chief Scientific Officer | S - Sale | $4.18 | -3,460 | 54,553 | -6% | -$14,456 | ||||||
2023-01-03 | PBYI | Nougues Maximo F | CFO | S - Sale | $4.18 | -10,499 | 100,427 | -9% | -$43,864 | ||||||
2023-01-03 | PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | S - Sale | $4.18 | -6,568 | 58,057 | -10% | -$27,440 | ||||||
2023-01-03 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $4.18 | -4,225 | 71,350 | -6% | -$17,652 | ||||||
2023-01-03 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $4.18 | -27,241 | 6,852,638 | 0% | -$113,810 | ||||||
2022-12-02 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $4.50 | -1,251 | 6,311,698 | 0% | -$5,627 | ||||||
2022-12-02 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $4.50 | -429 | 75,575 | -1% | -$1,930 | ||||||
2022-12-02 | PBYI | Nougues Maximo F | CFO | S - Sale | $4.50 | -159 | 110,926 | 0% | -$715 | ||||||
2022-12-02 | PBYI | Wong Alvin F | Chief Scientific Officer | S - Sale | $4.50 | -514 | 58,013 | -1% | -$2,312 | ||||||
2022-11-02 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $2.25 | -429 | 76,004 | -1% | -$965 | ||||||
2022-11-02 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $2.25 | -1,242 | 6,312,949 | 0% | -$2,795 | ||||||
2022-11-02 | PBYI | Nougues Maximo F | CFO | S - Sale | $2.25 | -163 | 111,085 | 0% | -$367 | ||||||
2022-10-03 | PBYI | Nougues Maximo F | CFO | S - Sale | $2.34 | -165 | 111,248 | 0% | -$385 | ||||||
2022-10-03 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $2.34 | -435 | 76,433 | -1% | -$1,016 | ||||||
2022-10-03 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $2.34 | -1,260 | 6,314,191 | 0% | -$2,943 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |